Kumquat Biosciences
United States · $70.0M raised
- Business Model
- B2B
- Website
- kumquatbiosciences.com
- Total Funding
- $70.0M
- Last Round
- $20.0M Series CFeb 2021
- Rounds
- 2
About
Kumquat Biosciences develops cancer medicines combining novel target drug molecules with immuno-oncology therapies to deliver durable therapeutic benefits.
Summary
Kumquat Biosciences is a Biotech company based in United States. It has raised $70.0M in total across 2 rounds, most recently a $20.0M Series C round in Feb 2021. Investors include Codon Capital, Sequoia Capital and EcoR1 Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...